These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35078337)

  • 21. Controlled Release of Dexamethasone From an Intravitreal Delivery System Using Porous Silicon Dioxide.
    Hou H; Wang C; Nan K; Freeman WR; Sailor MJ; Cheng L
    Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):557-66. PubMed ID: 26882530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs.
    Ahn SJ; Hong HK; Na YM; Park SJ; Ahn J; Oh J; Chung JY; Park KH; Woo SJ
    J Vis Exp; 2016 Jul; (113):. PubMed ID: 27500363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging, quantitation and kinetic modelling of intravitreal nanomaterials.
    Sadeghi A; Ruponen M; Puranen J; Cao S; Ridolfo R; Tavakoli S; Toropainen E; Lajunen T; Ranta VP; van Hest J; Urtti A
    Int J Pharm; 2022 Jun; 621():121800. PubMed ID: 35533923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-Dimensional Transport Model for Intravitreal and Suprachoroidal Drug Injection.
    Zhang Y; Bazzazi H; Lima E Silva R; Pandey NB; Green JJ; Campochiaro PA; Popel AS
    Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):5266-5276. PubMed ID: 30383198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A drug delivery analysis of large molecules in ocular vitreous chamber: Dependency on saccadic movements after intravitreal injection.
    Ferroni M; De Gaetano F; Cereda MG; Boschetti F
    Med Eng Phys; 2020 Aug; 82():49-57. PubMed ID: 32709265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal Anti-VEGF Injections Reduce Aqueous Outflow Facility in Patients With Neovascular Age-Related Macular Degeneration.
    Wen JC; Reina-Torres E; Sherwood JM; Challa P; Liu KC; Li G; Chang JY; Cousins SW; Schuman SG; Mettu PS; Stamer WD; Overby DR; Allingham RR
    Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1893-1898. PubMed ID: 28358961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The combination of IGF1 and FGF2 and the induction of excessive ocular growth and extreme myopia.
    Ritchey ER; Zelinka CP; Tang J; Liu J; Fischer AJ
    Exp Eye Res; 2012 Jun; 99():1-16. PubMed ID: 22695224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An anchoring molecule increases intravitreal retention of antibody-based therapeutics used in the treatment of ocular diseases.
    Gao Q; Schachar IH
    J Control Release; 2020 Dec; 328():263-275. PubMed ID: 32858075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microneedle scleral patch for minimally invasive delivery of triamcinolone to the posterior segment of eye.
    Roy G; Garg P; Venuganti VVK
    Int J Pharm; 2022 Jan; 612():121305. PubMed ID: 34800618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An assessment of the ocular safety of excipient maleic acid following intravitreal injection in rabbits.
    Aguirre SA; Collette W; Gukasyan HJ; Huang W
    Toxicol Pathol; 2012 Jul; 40(5):797-806. PubMed ID: 22552388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cyclic intraocular pressure on conventional outflow facility.
    Ramos RF; Stamer WD
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):275-81. PubMed ID: 18172103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrasound-responsive nanobubbles for enhanced intravitreal drug migration: An ex vivo evaluation.
    Thakur SS; Chen YS; Houston ZH; Fletcher N; Barnett NL; Thurecht KJ; Rupenthal ID; Parekh HS
    Eur J Pharm Biopharm; 2019 Mar; 136():102-107. PubMed ID: 30660691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Manipulation of intraocular pressure for studying the effects on accommodation.
    He L; Wendt M; Glasser A
    Exp Eye Res; 2012 Sep; 102():76-84. PubMed ID: 22814297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rabbit as an animal model for intravitreal pharmacokinetics: Clinical predictability and quality of the published data.
    Del Amo EM; Urtti A
    Exp Eye Res; 2015 Aug; 137():111-24. PubMed ID: 25975234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraocular pressure and injection forces during intravitreal injection into enucleated porcine eyes.
    Allmendinger A; Butt YL; Mueller C
    Eur J Pharm Biopharm; 2021 Sep; 166():87-93. PubMed ID: 34102300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ex vivo investigation of ocular tissue distribution following intravitreal administration of connexin43 mimetic peptide using the microdialysis technique and LC-MS/MS.
    Bisht R; Mandal A; Rupenthal ID; Mitra AK
    Drug Deliv Transl Res; 2016 Dec; 6(6):763-770. PubMed ID: 27371395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration.
    Amrite AC; Edelhauser HF; Singh SR; Kompella UB
    Mol Vis; 2008 Jan; 14():150-60. PubMed ID: 18334929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular hypothermia: anterior chamber perfusion.
    May DR; Freedland RJ; Charles S; Wang C; Bakos J
    Br J Ophthalmol; 1983 Dec; 67(12):808-13. PubMed ID: 6671095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicity and in vivo release profile of sirolimus from implants into the vitreous of rabbits' eyes.
    De Paiva MRB; Lage NA; Guerra MCA; Mol MPG; Ribeiro MCS; Fulgêncio GO; Gomes DA; Da Costa César I; Fialho SL; Silva-Cunha A
    Doc Ophthalmol; 2019 Feb; 138(1):3-19. PubMed ID: 30456454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.